Company Filing History:
Years Active: 2011
Title: Khanna Aparna: Innovator in Stem Cell Research
Introduction
Khanna Aparna is a notable inventor based in Navi, India. He has made significant contributions to the field of stem cell research, particularly in the development of pluripotent embryonic-like stem cells. His work has the potential to revolutionize therapeutic approaches for various diseases and conditions.
Latest Patents
Khanna Aparna holds a patent for "Pluripotent embryonic-like stem cells derived from corneal limbus, methods of isolation and uses thereof." This patent describes mammalian pluripotent embryonic-like stem cells (ELSCs) isolated from corneal limbal tissue, which is a non-embryonic tissue. The ELSCs are capable of proliferating in vitro and maintain the potential to differentiate into cells of endoderm, mesoderm, and ectoderm lineage. They can also form embryoid-like bodies when placed in suspension culture. This multi-lineage differentiation potential and self-renewing capability make ELSCs a promising therapeutic tool for various diseases, conditions, and injuries.
Career Highlights
Khanna Aparna is currently associated with Reliance Life Sciences Pvt. Ltd., where he continues to advance his research in stem cell technology. His innovative work has garnered attention in the scientific community and has the potential to lead to new therapeutic alternatives.
Collaborations
He has collaborated with notable colleagues such as Satish Mahadeorao Totey and Subhadra Devi Kashyap, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Khanna Aparna's contributions to stem cell research exemplify the impact of innovative thinking in the medical field. His work not only advances scientific knowledge but also holds promise for future therapeutic applications.